Interestingly, Yang et al. found that forced miR-206 expression restored gefitinib sensitivity in IL6-induced gefitinib-resistant EGFR-mutant lung cancer cells by inhibiting the IL6/JAK1/STAT3 pathway [30]. The gene discussed is EGFR; the disease is lung carcinoma.